Association between triglyceride glucose index and subclinical left ventricular systolic dysfunction in patients with type 2 diabetes

[1]  Jian Li,et al.  Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations , 2022, Cardiovascular Diabetology.

[2]  A. Avagimyan.  THE PATHOPHYSIOLOGICAL BASIS OF DIABETIC CARDIOMYOPATHY DEVELOPMENT. , 2022, Current problems in cardiology.

[3]  Da-Hye Son,et al.  Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  Ji Hu,et al.  Association between Diabetes Complications and the Triglyceride-Glucose Index in Hospitalized Patients with Type 2 Diabetes , 2021, Journal of diabetes research.

[5]  A. Lombardi,et al.  Heart failure in diabetes. , 2021, Metabolism: clinical and experimental.

[6]  L. Ernande,et al.  The role of hyperglycaemia in the development of diabetic cardiomyopathy. , 2021, Archives of cardiovascular diseases.

[7]  K. Hirata,et al.  Effect of heart rate on left ventricular longitudinal myocardial function in type 2 diabetes mellitus , 2021, Cardiovascular Diabetology.

[8]  O. Orasan,et al.  Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imaging , 2020, European journal of clinical investigation.

[9]  S. Del Prato,et al.  Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study , 2020, Diabetes Care.

[10]  E. Dikaiakou,et al.  Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents , 2020, Endocrine.

[11]  R. Gropler,et al.  Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy. , 2020, Circulation research.

[12]  R. Rodríguez‐Gutiérrez,et al.  Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review , 2020, International journal of endocrinology.

[13]  L. Cai,et al.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence , 2020, Nature Reviews Cardiology.

[14]  J. Sadoshima,et al.  Cardiomyopathy in obesity, insulin resistance and diabetes , 2020, The Journal of physiology.

[15]  C. Yancy,et al.  Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[16]  E. Abel,et al.  Heart Failure in Type 2 Diabetes Mellitus. , 2019, Circulation research.

[17]  A. Natali,et al.  Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial , 2017, Cardiovascular Diabetology.

[18]  J. Lekakis,et al.  Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage. , 2017, International journal of cardiology.

[19]  J. Sowers,et al.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease , 2017, Diabetologia.

[20]  J. Sowers,et al.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.

[21]  A. Fernández-Montero,et al.  The TyG index may predict the development of cardiovascular events , 2016, European journal of clinical investigation.

[22]  J. Lekakis,et al.  Association of impaired left ventricular twisting‐untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease , 2015, European journal of heart failure.

[23]  H. Shimoura,et al.  Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus , 2015, Cardiovascular Diabetology.

[24]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  P. Croisille,et al.  Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  M. Laakso,et al.  Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.

[27]  A. di Lenarda,et al.  The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study. , 2013, Diabetes research and clinical practice.

[28]  N. Dhalla,et al.  Role of microangiopathy in diabetic cardiomyopathy , 2013, Heart Failure Reviews.

[29]  C. Siu,et al.  Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress , 2012, Cardiovascular Diabetology.

[30]  A. di Lenarda,et al.  Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study , 2012, European journal of preventive cardiology.

[31]  A. Leite-Moreira,et al.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment , 2012, Heart Failure Reviews.

[32]  P. Croisille,et al.  Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? , 2011, Journal of the American Society of Echocardiography.

[33]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[34]  Michael Becker,et al.  Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. , 2009, JACC. Cardiovascular imaging.

[35]  R. Witteles,et al.  Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. , 2008, Journal of the American College of Cardiology.

[36]  H. Lebovitz.  Insulin resistance – a common link between type 2 diabetes and cardiovascular disease , 2006, Diabetes, obesity & metabolism.

[37]  D. Bell,et al.  Diabetic cardiomyopathy. , 2003, Diabetes care.

[38]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.